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Table1: Pre, per and post-operative details of the study eyes (N=161). Percents given are out of 
the total for which records were available. 
 
 
  present 
missing 
record 
  n (%) n 
 
PRE-OPERATIVE 
    
     
secondary glaucoma (uveitis, ocular 
trauma or vascular accident) 
13 (8%) 4 
 
advanced glaucoma (= cup/disc ≥ 0,8 ) 119 (79%) 10 
 
very high preoperative IOP (≥ 40mmHg) 38 (24%) 3 
 
     
preoperative WHO-VA category 
  
8 
 
normal vision 43 (28%) 
  
visual impairment 52 (34%) 
  
blind 58 (38%)   
 
     
PER-OPERATIVE 
    
scleral flap 
  
33 
 
fornix based 120 (94%) 
  
limbus based 8 (6%) 
  
     
simultaneuos cataract extraction 9 (7%) 33 
 
use  of releasable sutures 94 (60%) 3 
 
operated by one surgeon (SDS) 99 (67%) 14 
 
     
use of antimetabolite 
  
16 
 
none 17 (12%) 
  
5-Fluorouracil 33 (23%) 
  
mitomycin C 95 (66%) 
  
     
POST-OPERATIVE 
    
early complications (< 1 week postop)  27 (17%) 6 
 
late complications ( ≥ 1 week postop)  21 (14%) 11 
 
re-intervention needed 21 (13%) 4 
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Figure 1: Complications and re-interventions in the 161 study eyes. 
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Table 2: Ophthalmic findings at the time of the study visit (N=161). Percents given are out of 
the total for which records were available. 
 
 
  present 
missing 
records 
  n (%) n 
 
postoperative IOP ≤  15mmHg  113 (71%) 1 
 
postoperative IOP <  21mmHg  153 (96%) 1 
 
IOP reduction  of ≥ 30% 133 (85%) 4 
 
     
Bleb description 
    
white 61 (38%) 1 
 
elevated 121 (76%) 
2 
  
     
lens status 
  
3 
 
phakic 134 (85%) 
  
pseudophakic 19 (12%) 
  
aphakic  5 (3%) 
  
     
chronic uveitis 1 (1%) 1 
 
compliant to follow-up visits ( ≥ 5 visits 
after trabeculectomy) 
69 (43%) 0   
long total follow-up duration (≥ 2 years) 93 (58%) 0   
     
postoperative WHO-visual acuity category 
  
0    
normal vision 60 (37%) 
  
visual impairment 37 (23%) 
  
blind 64 (40%)     
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Table 3: Univariate and multivariate analysis of potential predictors for IOP 
failure (>20mmHg and/or <30% reduction) in first operated eyes (n= 118 eyes), 
expressed in absolute and relative number of eyes, odds ratio (OR), 95% 
confidence intervals (CI) and P-value. 
   
 
UNIVARIATE  ANALYSIS 
MULTIVARIATE 
ANALYSIS 
Predictors OR CI P-value OR CI 
P-
value 
compliant to follow-up visits ( ≥ 5 visits) 1.08 0.407-2.46 0.88 
   
male gender 1.087 0.407- 2.941 0.86 1.229 0.413-3.663 0.711 
young age at operation (< 51 years) 0.741 0.224- 2.439 0.62 0.977 0.274-3.485 0.971 
long total follow-up duration (≥ 2 
years) 
3.571 1.087- 12.5 0.03 2.90 0.864-9.730 0.085 
use  of releasable sutures 0.503 0.183- 1.370 0.17 
   
use of any antimetabolite 0.346 0.862- 1.333 0.11 0.353 0.089-1.402 0.139 
use of mitomycine C compared to the 
rest 
0.386 0.135- 1.111  0.07 
   
3 min duration of mitomycine C 
application 
0.781 0.143- 4.348 0.78 
   
early complications (< 1 week postop)  0.758 0.198- 2.941 0.68 
   
late complications ( ≥ 1 week postop)  1.667 0.469- 5.882 0.42 
   
reintervention needed 1.087 0.277- 4.348 0.91 
   
advanced glaucoma  (cup/disc ≥ 0,8 ) 1.587 0.498- 5.263 0.45 
   
very high preoperative  IOP (≥ 40mmHg) 0.495 0.132- 1.852 0.29 
   
fornix based trabeculectomy technique 1.149 0.127- 10 0.90 
   
combined with cataract operation 0.735 0.083- 6.667 0.78 
   
secondary glaucoma 0.633 0.073- 5.556 0.67 
   
operated by one surgeon (SDS) 0.565 0.193- 1.639 0.29       
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Figure 2: Cumulative probability to maintain good outcome (intraocular pressure IOP << 21mmHg  and a 30% 
IOP reduction after trabeculectomy) for the first eyes only. 
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